Unitedhealth (UNH) Stock
Major US health insurer with benefits and care services. Here's the price, business snapshot, and what's worth knowing about Unitedhealth in August 2026.
UnitedHealth Group Incorporated (UNH) is one of the largest health insurers and healthcare services companies in the United States, combining health benefits with a fast-growing healthcare services arm (Optum). Investors should know it benefits from recurring revenue through insurance premiums and diversified fee-based services such as care delivery, pharmacy services and technology-enabled administration. The group’s scale supports margins and cash generation, but it operates in a highly regulated sector where policy changes, reimbursement pressures and litigation can affect results. With a market capitalisation of about $330.91B, UNH has a track record of steady cash flow, dividends and share buybacks, though past performance is not a guarantee of future returns. Suitable for investors who understand healthcare cycles and regulatory risk, it may not suit those seeking short-term, low-volatility holdings. This is general information and not personalised investment advice.
Why It’s Moving
UNH stays in focus as analysts lean on durable earnings power and still-see room for re-rating.
- Analysts have kept a broadly constructive stance on UNH, with several recent research notes clustering around the mid-$400s and implying meaningful room for upside from current trading levels, which has helped steady sentiment around the name.
- The latest analyst enthusiasm is being tied to expectations that UnitedHealth can keep compounding earnings through its scale in managed care and Optum, even as investors continue to watch margins and medical cost trends closely.
- Recent forecast revisions suggest the market is re-evaluating how much of UnitedHealth’s long-term earnings power is already priced in, and that shift has kept the stock in focus as a defensive growth play within healthcare.
UNH stays in focus as analysts lean on durable earnings power and still-see room for re-rating.
- Analysts have kept a broadly constructive stance on UNH, with several recent research notes clustering around the mid-$400s and implying meaningful room for upside from current trading levels, which has helped steady sentiment around the name.
- The latest analyst enthusiasm is being tied to expectations that UnitedHealth can keep compounding earnings through its scale in managed care and Optum, even as investors continue to watch margins and medical cost trends closely.
- Recent forecast revisions suggest the market is re-evaluating how much of UnitedHealth’s long-term earnings power is already priced in, and that shift has kept the stock in focus as a defensive growth play within healthcare.
When is the next earnings date for UNITEDHEALTH GROUP INC (UNH)?
UnitedHealth Group’s next earnings date is most commonly estimated for October 27, 2026, though some services still show the date as not yet formally confirmed. The report is expected to cover Q3 2026 results. This timing is based on the company’s typical late-October earnings pattern.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying UnitedHealth's stock with a target price of $542.53, indicating strong growth potential.
Financial Health
UnitedHealth Group is performing well with strong revenue and cash flow, indicating solid financial stability.
Dividend
UnitedHealth Group's dividend yield of 2.22% is decent, making it suitable for those seeking some income from their investments. If you invested $1000 you would be paid $22.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
CHEMED CORP
Provides hospice and palliative care services to patients facing life-limiting illness
Brookdale
A leading owner and operator of senior living communities in the United States.
ACADIA HEALTHCARE
Provides behavioral health care services in the United States.
Baskets Featuring UNH
Medicare Advantage Rate Hike Opportunities in 2026
The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.
Published: 10 April 2026
Explore BasketJob Growth Surge: Which Industries Could Capitalise?
ADP reported that the private sector added 62,000 jobs in March, beating expectations and highlighting strong wage gains for job-changers. This steady labor market resilience presents a compelling investment case for healthcare providers, educational services, and human capital management firms.
Published: 2 April 2026
Explore BasketBlue-Chip Tech Stocks (After Buffett's Apple Regret)
Warren Buffett has publicly regretted selling Apple shares too early, indicating Berkshire Hathaway would buy more if prices drop significantly. This creates a unique moment to explore value-oriented tech stocks and supply chain partners that might present better current entry points.
Published: 2 April 2026
Explore BasketSemiconductor Patent Disputes (Foundry Market Impact)
GlobalFoundries has launched a major patent infringement lawsuit against Tower Semiconductor to protect its proprietary manufacturing technologies. This legal dispute underscores the growing importance of intellectual property enforcement in the competitive semiconductor sector, creating opportunities for rival foundries and IP-focused tech firms.
Published: 27 March 2026
Explore BasketRegulatory Relief Stocks | FTC Court Ruling Impact
A federal appeals court has overturned an FTC order against Intuit, significantly limiting the agency's ability to use internal judges. This precedent forces regulators to face higher burdens of proof in federal court, providing potential relief to corporations fighting administrative overreach.
Published: 21 March 2026
Explore BasketDefensive Equities | Risks in a Slowing Labour Market
After the U.S. economy unexpectedly shed 92,000 jobs in February, investors are seeking shelter from the resulting market volatility. This collection features resilient, non-cyclical companies that historically maintain their value and offer stability during periods of economic deceleration.
Published: 9 March 2026
Explore BasketDefensive Havens: What's Next After Job Losses
The unexpected loss of 92,000 jobs in February signals growing vulnerability in the U.S. labor market. This economic uncertainty creates an investment opportunity in defensive stocks, as consumers and investors alike seek stability in essential businesses.
Published: 7 March 2026
Explore BasketUS Jobs Surge | Healthcare & Construction Stocks
The U.S. labor market showed surprising strength in January, adding far more jobs than anticipated, led by the healthcare and construction industries. This theme focuses on the companies benefiting from this robust and targeted hiring, signaling a potential expansion in these key sectors.
Published: 12 February 2026
Explore BasketBlue-Chip Stocks Rally Beyond 50K Mark in 2025
The Dow Jones Industrial Average's historic breach of the 50,000 mark highlights a powerful rebound in the market, led by blue-chip stocks. This event signals a potential investment opportunity in established companies within the financial and industrial sectors that are demonstrating strength and stability.
Published: 7 February 2026
Explore BasketWhy You’ll Want to Watch This Stock
Steady cash flow
Insurance premiums and high-margin services provide predictable cash generation, though results can vary with claims experience and regulation.
Vertical integration focus
Optum’s mix of care, pharmacy and data is aimed at efficiency and growth, but execution and competition remain important risks.
Policy sensitivity
Legislation and regulatory decisions can materially affect revenue and margins, so investors should monitor policy developments.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
